Ovizio

We bring automated cell-monitoring solutions for cell & gene therapy, vaccine industry and life sciences applications. Our microscopes are easy-to-use, label-free and non-invasive tools for the three-dimensional, real-time imaging of living cells. Based on patented differential digital holography technology, our advanced systems generate reliable, high-quality holographic images providing highly-reproducible tracking of: - cell density - morphology - cell viability - viral infection kinetics - cell activation status Direct Benefits Our technology can benefit a range of applications, from R&D to manufacturing processes, and enable significant cost reduction and quality improvement. Our microscopes are particularly convenient and robust for automated cell...

Cell viability,t cells,hek cells,viral vectors,cgmp,car-t,gene therapy,vaccine production,bioprocessing,manufacturing,cell therapy,holographic imaging,3d microscopy,flow cytometry,cell counting,imaging living cells,viral load detection,machine learning software,microcarriers,and microcarrier

Ovizio operates in the Biotechnology research industry.

Ovizio's revenue is 11m - 100m

Ovizio has 11 - 50 employees.